Matches in SemOpenAlex for { <https://semopenalex.org/work/W2037659918> ?p ?o ?g. }
- W2037659918 endingPage "374" @default.
- W2037659918 startingPage "370" @default.
- W2037659918 abstract "We aimed to evaluate the efficacy of tocilizumab in patients with rheumatoid arthritis (RA), using the clinical disease activity index (CDAI), and to determine the baseline variables associated with CDAI remission. Fifty-eight patients with active RA were enrolled. We tried to evaluate whether baseline variables were associated with CDAI remission at 24 weeks. Twenty-two of the 58 patients (37.9%) had received tumor necrosis factor (TNF) inhibitors. The continuation rate of tocilizumab at 24 weeks was 87.9%. The seropositivity rates of IgM-rheumatoid factor (RF) and anti-cyclic citrullinated peptide (anti-CCP) antibodies at baseline were both 91.4%. The rate of CDAI remission at 24 weeks was 20.7%. We selected baseline variables including age, gender, duration of disease, concomitant use of glucocorticoids, concomitant use of methotrexate (MTX), previous anti-TNF therapy, titer of anti-CCP antibodies (high or low toward median), titer of IgM-RF (high or low toward median), and CDAI, and found that a high titer of IgM-RF was the only variable to be associated with CDAI remission, according to univariate and logistic regression analyses. This is a new finding, and may be specific to tocilizumab as compared with previous observations in anti-TNF therapy." @default.
- W2037659918 created "2016-06-24" @default.
- W2037659918 creator A5000556430 @default.
- W2037659918 creator A5019615899 @default.
- W2037659918 creator A5022076444 @default.
- W2037659918 creator A5035859888 @default.
- W2037659918 creator A5044442302 @default.
- W2037659918 creator A5050158822 @default.
- W2037659918 creator A5056681640 @default.
- W2037659918 creator A5057574490 @default.
- W2037659918 creator A5070326257 @default.
- W2037659918 creator A5074758212 @default.
- W2037659918 creator A5082577947 @default.
- W2037659918 creator A5084299259 @default.
- W2037659918 creator A5089657463 @default.
- W2037659918 creator A5091177614 @default.
- W2037659918 date "2011-01-15" @default.
- W2037659918 modified "2023-09-26" @default.
- W2037659918 title "In rheumatoid arthritis patients treated with tocilizumab, the rate of clinical disease activity index (CDAI) remission at 24 weeks is superior in those with higher titers of IgM-rheumatoid factor at baseline" @default.
- W2037659918 cites W1588610010 @default.
- W2037659918 cites W1981863815 @default.
- W2037659918 cites W1987192197 @default.
- W2037659918 cites W2063485775 @default.
- W2037659918 cites W2069454919 @default.
- W2037659918 cites W2069473482 @default.
- W2037659918 cites W2089464411 @default.
- W2037659918 cites W2096862304 @default.
- W2037659918 cites W2098896429 @default.
- W2037659918 cites W2139339400 @default.
- W2037659918 cites W2150952126 @default.
- W2037659918 cites W2152348310 @default.
- W2037659918 cites W2156959186 @default.
- W2037659918 cites W2162539122 @default.
- W2037659918 doi "https://doi.org/10.1007/s10165-010-0409-0" @default.
- W2037659918 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21240618" @default.
- W2037659918 hasPublicationYear "2011" @default.
- W2037659918 type Work @default.
- W2037659918 sameAs 2037659918 @default.
- W2037659918 citedByCount "10" @default.
- W2037659918 countsByYear W20376599182012 @default.
- W2037659918 countsByYear W20376599182014 @default.
- W2037659918 countsByYear W20376599182015 @default.
- W2037659918 countsByYear W20376599182017 @default.
- W2037659918 countsByYear W20376599182018 @default.
- W2037659918 countsByYear W20376599182021 @default.
- W2037659918 countsByYear W20376599182022 @default.
- W2037659918 crossrefType "journal-article" @default.
- W2037659918 hasAuthorship W2037659918A5000556430 @default.
- W2037659918 hasAuthorship W2037659918A5019615899 @default.
- W2037659918 hasAuthorship W2037659918A5022076444 @default.
- W2037659918 hasAuthorship W2037659918A5035859888 @default.
- W2037659918 hasAuthorship W2037659918A5044442302 @default.
- W2037659918 hasAuthorship W2037659918A5050158822 @default.
- W2037659918 hasAuthorship W2037659918A5056681640 @default.
- W2037659918 hasAuthorship W2037659918A5057574490 @default.
- W2037659918 hasAuthorship W2037659918A5070326257 @default.
- W2037659918 hasAuthorship W2037659918A5074758212 @default.
- W2037659918 hasAuthorship W2037659918A5082577947 @default.
- W2037659918 hasAuthorship W2037659918A5084299259 @default.
- W2037659918 hasAuthorship W2037659918A5089657463 @default.
- W2037659918 hasAuthorship W2037659918A5091177614 @default.
- W2037659918 hasConcept C126322002 @default.
- W2037659918 hasConcept C144301174 @default.
- W2037659918 hasConcept C151956035 @default.
- W2037659918 hasConcept C159654299 @default.
- W2037659918 hasConcept C198451711 @default.
- W2037659918 hasConcept C203014093 @default.
- W2037659918 hasConcept C2776232647 @default.
- W2037659918 hasConcept C2777178219 @default.
- W2037659918 hasConcept C2777575956 @default.
- W2037659918 hasConcept C2779384505 @default.
- W2037659918 hasConcept C2781059491 @default.
- W2037659918 hasConcept C32611913 @default.
- W2037659918 hasConcept C38180746 @default.
- W2037659918 hasConcept C71924100 @default.
- W2037659918 hasConcept C90924648 @default.
- W2037659918 hasConceptScore W2037659918C126322002 @default.
- W2037659918 hasConceptScore W2037659918C144301174 @default.
- W2037659918 hasConceptScore W2037659918C151956035 @default.
- W2037659918 hasConceptScore W2037659918C159654299 @default.
- W2037659918 hasConceptScore W2037659918C198451711 @default.
- W2037659918 hasConceptScore W2037659918C203014093 @default.
- W2037659918 hasConceptScore W2037659918C2776232647 @default.
- W2037659918 hasConceptScore W2037659918C2777178219 @default.
- W2037659918 hasConceptScore W2037659918C2777575956 @default.
- W2037659918 hasConceptScore W2037659918C2779384505 @default.
- W2037659918 hasConceptScore W2037659918C2781059491 @default.
- W2037659918 hasConceptScore W2037659918C32611913 @default.
- W2037659918 hasConceptScore W2037659918C38180746 @default.
- W2037659918 hasConceptScore W2037659918C71924100 @default.
- W2037659918 hasConceptScore W2037659918C90924648 @default.
- W2037659918 hasIssue "4" @default.
- W2037659918 hasLocation W20376599181 @default.
- W2037659918 hasLocation W20376599182 @default.
- W2037659918 hasOpenAccess W2037659918 @default.
- W2037659918 hasPrimaryLocation W20376599181 @default.
- W2037659918 hasRelatedWork W1971595431 @default.
- W2037659918 hasRelatedWork W1987294331 @default.